CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 305,896	$ 316,827
Marketable securities, at fair value	175,534	198,563
Accounts receivable, net	110,796	112,130
Inventories	23,840	23,395
Prepaid assets	14,341	12,354
Assets held for sale	0	10,050
Other current assets	20,693	8,189
Total current assets	651,100	681,508
Property and equipment (net of accumulated depreciation of $116,254 and $109,952, respectively)	108,942	109,465
Operating lease right-of-use assets	101,955	102,197
Intangible assets, net	433,835	442,325
Goodwill	527,115	527,115
Other assets	6,600	7,168
Total non-current assets	1,178,447	1,188,270
Total assets	1,829,547	1,869,778
Current liabilities
Accounts payable	20,481	17,921
Accrued compensation	32,320	38,304
Accrued expenses and other liabilities	16,571	17,796
Current portion of equipment financing obligations	621	1,135
Current portion of operating lease liabilities	5,958	6,884
Pharma contract liabilities	6,119	5,192
Total current liabilities	82,070	87,232
Long-term liabilities
Convertible senior notes, net	533,189	532,483
Operating lease liabilities	73,434	72,289
Deferred income tax liabilities, net	51,709	55,475
Other long-term liabilities	14,141	14,022
Total long-term liabilities	672,473	674,269
Total liabilities	754,543	761,501
Commitments and contingencies (Note 11)
Stockholders’ equity
Common stock, $0.001 par value, (250,000,000 shares authorized; 124,722,215 and 124,107,500 shares issued and outstanding, respectively)	125	124
Additional paid-in capital	1,142,133	1,123,628
Accumulated other comprehensive loss	(3,009)	(638)
Accumulated deficit	(64,245)	(14,837)
Total stockholders’ equity	1,075,004	1,108,277
Total liabilities and stockholders’ equity	$ 1,829,547	$ 1,869,778